) is a small proteolipid and a regulator of sarco(endo)plasmic reticulum Ca 2ϩ -ATPase. In heart tissue, SLN is exclusively expressed in the atrium. Previously, we inserted Cre recombinase into the endogenous SLN locus by homologous recombination and succeeded in generating SLN-Cre knockin (Sln Cre/ϩ ) mice. This Sln Cre/ϩ mouse can be used to generate an atrium-specific gene-targeting mutant, and it is based on the Cre-loxP system. In the present study, we used adult Sln Cre/ϩ mice atria and analyzed the effects of heterozygous SLN deletion by Cre knockin before use as the gene targeting mouse. Both SLN mRNA and protein levels were decreased in Sln Cre/ϩ mouse atria, but there were no morphological, physiological, or molecular biological abnormalities. The properties of contractility and Ca 2ϩ handling were similar to wild-type (WT) mice, and expression levels of several stress markers and sarcoplasmic reticulum-related protein levels were not different between Sln
THE DEVELOPMENT of gene-targeting approaches has had a tremendous impact on the functional analysis of the mouse heart. The bacteriophage P1 Cre/loxP site-specific recombinase system allows for precise recombination between two loxP sites, resulting in deletion of the targeting gene in a time-and/or tissue-specific manner. Although many heart muscle-specific conditional knockout (KO) mice have been generated, there are few atrium-specific conditional KO mice. de Lange et al. (6) have generated mice that have atrial cardiomyocyte-specific Cre expression using the natriuretic peptide type A (Nppa) gene promoter (6) . However, Cre expression in this mouse was observed in part of the ventricle. The Nppa gene is also highly induced in the ventricle by stresses such as pressure overload (23) . In this research, we focused on sarcolipin (SLN), which is a 31-amino acid proteolipid that regulates the activity of sarco(endo)plasmic reticulum Ca 2ϩ -ATPase (SERCA) (21, 25, 37) , because SLN is expressed specifically in atrial muscle from early developmental stages around embryonic day 10.5 and throughout life (21, 25) . On the other hand, phospholamban (PLN), a homolog of SLN, is known to be expressed in both the atrium and ventricle, and PLN is particularly abundant in ventricular muscle (21) . In the cardiovascular research field, previous studies have reported several effects of SLN deletion and/or overexpression such that SLN deletion indicates enhanced atrial contractility, whereas SLN overexpression indicates decreased myocyte contractility (2, 3, 10) . In our previous study (25) , we generated SLN-Cre knockin (KI) mice. This KI mouse is a new mouse model that enables us to delete optional genes specifically in atrial muscle using the Cre/loxP system. In other words, the SLN-Cre KI mouse has the potential to generate a novel atrium-specific gene-targeting mutant. However, because SLN in the KI mouse is deleted in response to Cre recombinase insertion, the effects of heterozygous SLN deletion in the atrium have to be evaluated before an atriumspecific conditional KO mouse can be generated. As mentioned above, the effects of SLN deletion have been reported using SLN-null mice. However, little has been reported on the comparison between wild-type (WT) and SLN mutant heterozygous mice. Therefore, in the present study, we aimed to examine the functional and structural effects of SLN heterozygous deletion (Sln Cre/ϩ ) at baseline or after chronic ␤-adrenergic stimuli. Through the present study, we would like to show that SLN-Cre KI mice are appropriate for atriumspecific gene targeting in a future study.
MATERIALS AND METHODS
Animals. The SLN targeting construct has been described elsewhere (25) . Cre recombinase cDNA was placed into the endogenous Sln exon 2 locus by homologous recombination. The present study used heterozygous SLN mutants (Sln Cre/ϩ ), which have one copy of Cre recombinase cDNA in the Sln locus, and WT littermates. The following primers were used for genotyping: SLN, forward 5=-ACGGGAAGGGTTGGCAAGTCA-3= and reverse 5=-GTGTGGGT-CAGAGATGCTGGA-3=; and Cre recombinase, same forward primer as SLN and reverse 5=-TCCTCTTCTTCTTGGGCATGG-3=. All animal care and study protocols were approved by the Animal Ethics Committees of Waseda University and Jikei University, and the investigation conformed with the National Institutes of Health Guide for the Care and Use of Laboratory Animals (NIH Pub. No. 85-23, Revised 1996) . Male and female mice aged 3-6 mo were studied to ensure uniformity among experimental subjects. As previously described (33), mice had free access to normal chow and water. Animals were individually housed in Plexiglas cages and kept in a room with a controlled temperature (22 Ϯ 3°C) and light cycle (lights on from 8:00 AM to 8:00 PM). For histological analysis, we purchased male C57BL6 mice as WT mice from Sankyo Lab (Japan) and bred them under the same conditions.
Chronic ␤-adrenergic stimulation model. Isoproterenol (Iso) was chronically infused using a microosmotic pump (Alzet Micro-Osmotic Pump model 1002, Durect). Iso was dissolved in saline (30 g·g body wt Ϫ1 ·day Ϫ1 ) and infused for 2 wk. Control mice (WT littermates) received the pump filled with saline for 2 wk (saline-stimulated WT group). After 2 wk, mice were subjected to echocardiography and molecular and histological analyses (15) .
Echocardiography. Mice were anesthetized with 4% isoflurane, which was decreased to 1.4% isoflurane after the mouse was sufficient anesthetized. We measured cardiac function parameters, including end-systolic and diastolic left ventricular (LV) internal diameter (LVIDs and LVIDd, respectively), interventricular septal thickness, LV posterior wall thickness, heart rate (HR), and fractional shortening, using transthoracic echocardiography using a Toshiba Aplio instrument and a 14-MHz linear transducer (PLT-1202S, Toshiba) or a GE Vivid i8 ultra sound system (GE Healthcare, Milwaukee, WI) and Echo Pac software (GE Healthcare) just before heart isolation.
Heart isolation. After echocardiography, heart tissues were immediately isolated under isoflurane anesthesia, as previously described (33) . Hearts were separated into three parts (both atria, the LV, and the right ventricle) and immediately frozen with liquid nitrogen after each tissue's weight was measured.
Sarcoplasmic reticulum ATPase activity assay. We extracted sarcoplasmic reticulum (SR) proteins from the atria, as described elsewhere (13) . SR ATPase activity was assayed using an ATPase activity assay kit (GM3050, GenoMembrane) according to the manufacturer's instructions and a previous study (14) . The SR protein concentration was determined using the bicinchoninic acid method.
Simultaneous measurement of tension and intracellular Ca 2ϩ concentration. We injected heparin (0.1 ml by intraperitoneal administration) 10 min before heart isolation and used the left atrium to measure tension and intracellular Ca 2ϩ concentration ([Ca 2ϩ ]i). We isolated and tied the top and bottom of the left atrial appendages with 10-0 silk threads and horizontally set them to the hook of the tension transducers. The left atrial appendages were contracted at 1.0 Hz using field electrical stimulation from a pair of platinum electrodes and adding two-to threefold higher than the threshold voltage to measure tension. During measurements, oxygenated HEPES-Tyrode solution [containing 137 mM NaCl, 5 mM KCl, 0.5 mM MgCl 2, 0.3 mM NaH2PO4, 5 mM HEPES, 5 mM glucose and 2 mM CaCl2; pH adjusted to 7.4 (12) ] was perfused in the specimen chamber. We stretched the specimen to its maximum tension in HEPES-Tyrode solution containing 8 mM Ca 2ϩ at room temperature. We then microinjected aequorin, which is a Ca 2ϩ -sensitive photoprotein extracted from jellyfish, into 50 -100 superficial atrial cells in a solution containing HEPES-Tyrode solution plus 20 mM 2,3-butanedione monoxime to measure [Ca 2ϩ ]i, as previously described using the mouse ventricular myocardium (12 Cre/ϩ mice. LV, left ventricle; RV, right ventricle; BW, body weight. There were no significant differences in any of the parameters.
described (1, 12) . We also measured the following parameters for twitch contraction in HEPES-Tyrode solution containing 8 mM Ca 2ϩ and 1 M Iso: the time to peak light and tension measured from the onset of stimulus to the peaks and light decay time and relaxation time, which is the time for the light signal to decay or for tension to relax from 75% to 25% of the peak, as previously described previously (12) .
Electrophysiological experiments. We administered intraperitoneal heparin to mice 10 min before heart dissection. Mice were anesthetized using pentobarbital (65 mg/g body wt ip), and hearts were Cre/ϩ mouse atria were decreased compared with WT mouse atria. GAPDH and ␤-actin were used as internal controls, respectively (A and B). C: there was no significant difference in SERCA activity between WT and Sln Cre/ϩ mouse atria. Values are expressed as means Ϯ SE; n ϭ 3-6. **P Ͻ 0.01 and ***P Ͻ 0.001 compared with WT mice.
isolated. We cannulated a 21-gauge needle into the aorta and started Langendorff perfusion. First, we perfused iced PBS (Ca 2ϩ free) and set the heart on the pacing electrode. We inserted a catheter from the superior vena cava and placed the electrode at the right atrial appendage. The heart was then perfused with Tyrode solution containing 1.8 mM Ca 2ϩ at 4 ml/s and 36°C for 5 min to wash out blood. This was followed by a perfusion of di-4-ANEPPS, which is known as voltagesensitive dye, for 7.5 min, which was washed out by perfusing Tyrode solution for 5 min. Finally, we perfused 5 M blebbistatin for 5 min and started pacing the heart. We continued pacing at 150 ms as a basic cycle length (BCL) and gradually decreased energy output from 5 V. After the threshold voltage was determined, we added twofold higher voltage than the threshold for the experiment.
To measure a maximum of 1:1 conduction, we shortened BCL by 10 ms from 150 ms with continuous stimulation. We defined the shortest cycle length that had a stimulation and response of 1:1 as the maximum 1:1 conduction.
We measured the atrial effective refractory period (AERP) at each BCL [150, 120, and 90 ms, stimulus 1 (S1)] followed by the extrastimulus [stimulus 2 (S2)] (7, 18). After 10 beats of S1, we added a single S2 in each BCL. The S1-S2 interval was shortened by 5 ms until the atrial propagated response disappeared.
Atrial fibrillation (AF) was induced by three consecutive extrastimuli pacing at each BCL (150, 120, and 90 ms) and burst pacing (18, 30) . The first extrastimulation (S2) was initially set at 80 -150 ms after the 10th BCL stimulation and shortened by 5 ms until it reached the AERP. The other two extrastimulus intervals were initially set at AERP plus 30 ms and shortened by 5 ms until the AERP was reached. We observed tachycardia after each extrastimulus. In burst pacing, we successively paced for 99 beats at a beat per 100 ms. The interval was shortened by 10 ms up to a beat per 20 ms. We defined tachycardia that repeated for Ͼ10 beats as AF and Ͻ10 beats as a repetitive atrial response.
The action potential duration (APD) was measured at each BCL (150, 120, and 90 ms). APD was determined by measuring the decay time to 50%, 70%, and 90% of the fluorescence intensity of di-4-ANEPPS.
Immunohistochemistry and histological analysis. Immunohistochemistry was performed as previously described (26) . Sln
Cre/ϩ mice were crossed with R26R enhanced yellow fluorescent protein (eYFP) reporter mice (stock no. 006148, The Jackson Laboratory), and we used their offspring (Sln Cre/ϩ :R26R eYFP flox/ϩ ) at embryonic day 13.5 for immunohistochemistry.
To perform histological analysis, we used 5-mo-old mice. Heart tissue was fixed in 10% formaldehyde for 48 h at 4°C and washed twice with iced PBS for 30 min. Tissues were then dehydrated and embedded in paraffin by the following process: 100% ethanol for 2 h (6 times), xylene for 1.5 h (4 times), and paraffin for 1.5 h (4 times), followed by embedding in a block in paraffin.
Paraffin-embedded sections were prepared, and picrosirius red staining (Polysciences, , Warrington, PA) and elastica van Gieson staining (Muto Pure Chemical) were applied according to the manufacturers' instructions. We added picrosirius red solution instead of fuchsine to make van Gieson solution, according to the protocol at http://immuno2.med.kobe-u.ac.jp/20090119-3442/. We quantified positive and negative stained areas in right atria using Image-Pro Premier (MediaCybernetics, Rockville, MD). We added the positive and negative areas to calculate the total area.
Quantitative RT-PCR analyses. We performed quantitative RT-PCR as previously described (33) . Briefly, total RNA was extracted from atria using TRIzol reagent (Invitrogen, Carlsbad, CA) or Sepasol RNA I Super G (Nacalai Tesque) as recommended by the manufac- turer with some modification. Quantitative RT-PCR was performed using a QuantiTect SYBR Green RT-PCR Kit (Qiagen, Valencia, CA) and TaKaRa Thermal Cycler Dice (TaKaRa) as recommended by the manufacturer. We used the primers shown in Table 1 . Target mRNA expression was normalized to GAPDH mRNA expression.
Western blot analysis. Total protein was extracted from atria and used for Western blot analyses including antibodies against SLN (a gift from Dr. Chikashi Toyoshima, University of Tokyo), SERCA2 (S1314, Sigma, St. Louis, MO), Na ϩ /Ca 2ϩ exchanger 1 (NCX1; a gift from Dr. Takahiro Iwamoto, Fukuoka University), calsequestrin 2 (CSQ2; PA1-913, Affinity BioReagents, Golden, CO), PLN (total and phosphorylated PLN at Ser 16 and Thr 17 , A010-14, A010-12, and A010-13, respectively, Badrilla, Leeds, UK), ryanodine receptor (RyR; total and phosphorylated RyR at Ser 2808 , MA3-916, Affinity BioReagents, Golden, CO, and a gift from Andy Marks Lab, Columbia University, respectively), and ␤-actin (A5441, Sigma), as previously described (14) . Briefly, tissues were homogenized in ice-cold buffer [10 mM imidazole (pH 7.0), 300 mM sucrose, 5 mM sodium pyrophosphate decahydrate, and 1 mM DTT] with protease inhibitors (Complete Mini, Roche, Basel, Switzerland). To detect SLN, PLN, and RyR (including phosphorylated PLN and RyR), we extracted proteins using cell lysis buffer (no. 9803, Cell Signaling, Danvers, MA) with protease inhibitors (Complete Mini and 1 mM PMSF). Protein content was determined using the Bradford assay (Bio-Rad, Hercules, CA) and/or bicinchoninic acid methods (Thermo Fisher Scientific, Waltham, MA). BSA was used as a standard. Protein samples were separated using SDS-PAGE or NuPAGE electrophoresis (Invitrogen) and transferred to polyvinylidene difluoride membranes (Millipore, Billerica, MA). To detect pentamer PLN, we applied unboiled sample to the gel. When the molecular size of the target proteins was different, membranes were cut based on their size. When the molecular size of the target proteins was similar, we reused the same membrane for a different antibody after washing the membrane with stripping buffer [62.5 mM Tris (pH 6.8), 100 mM 2-mercaptoethanol, and 2% SDS]. After application of a secondary antibody, quantification of the target signals was performed using the LAS-3000 imaging system (Fujifilm, Tokyo, Japan) or EZ-Capture MG (ATTO, Tokyo, Japan).
Statistical analysis. Group data are presented as means Ϯ SE. Statistical analysis was performed using ANOVA and/or a Student's t-test. P values of Ͻ0.05 were considered significant.
RESULTS

Global morphology of the heart and expression levels of Sln and other Ca 2ϩ -handling proteins were not changed in Sln
Cre/ϩ mice. Sln Cre/ϩ mice survived for a normal lifespan and showed normal global morphology of the heart. We measured Values are expressed as means Ϯ SE; n ϭ 13 WT mice and 9 Sln Cre/ϩ mice. LVIDd, end-diastolic LV internal diameter; LVIDs, end-systolic LV internal diameter; IVSTd, end-diastolic wall thickness of the interventricular septum; IVSTs, end-systolic wall thickness of the interventricular septum; LVPWTd, end-diastolic LV posterior wall thickness; LVIDs, end-systolic LV posterior wall thickness; HR, heart rate; FS, fractional shortening. There were no significant differences in any of the parameters. the weight ratio of each cardiac chamber to the body weight and/or tibia length. There was no significant difference in the ratios between WT and Sln Cre/ϩ mice ( Table 2) . We also showed, using Sln Cre/ϩ :R26R eYFP flox/ϩ mice at embryonic day 13.5 , that Cre recombinase specifically worked in the atrium (Fig. 1) . eYFP-positive cells were observed in the atrium but not in the ventricle. These are consistent with a previous study using LacZ (25) .
Because of homologous recombination of Cre into the SLN locus, levels of Sln mRNA in Sln
Cre/ϩ mice were significantly decreased to 39.0 Ϯ 4.1% of those in WT mice (Fig. 2A) . Sln protein expression in Sln Cre/ϩ mice was also significantly decreased to 42.7 Ϯ 15.6% of those in WT mice (Fig. 2B) . In addition, homogenates from atrial tissues showed no difference in SERCA activities between WT and Sln Cre/ϩ mice (Fig. 2C ). Because expression levels of Ca 2ϩ -handling proteins such as SERCA2, CSQ2, NCX1, RyR, and PLN are critical for the regulation of cardiac function, we analyzed the expression levels of these proteins using Western blot analysis (Fig. 3) . These protein levels were not changed in Sln
Cre/ϩ mice compared with WT mice. In addition, PLN, a homolog of SLN, is also known to be phosphorylated at Ser 16 and Thr 17 , and phosphorylated PLN (inactivated state) consequently increases SERCA activity (28, 38) . Western blot analyses revealed that phosphorylated Ser 16 and Thr 17 PLN expression levels were not altered in Sln
Cre/ϩ mice compared with WT mice (Fig. 3) . We also analyzed the expression levels of cardiac stress markers such as atrial natriuretic factor, brain natriuretic peptide, ␣-and ␤-myosin heavy chain, and ␣-skeletal actin mRNAs using quantitative RT-PCR. All markers did not show any significant differences between WT and Sln Cre/ϩ mice (Fig. 4) .
Global ventricular function was not changed in Sln
Cre/ϩ mice. To evaluate cardiac function, we performed echocardiography (Table 3) . Even though it is difficult to evaluate the function of the atrium using echocardiography, we assessed the effects of heterozygous deletion of the Sln gene on cardiac function as a pump. All parameters we measured did not show any significant differences between WT and Sln Cre/ϩ mice. ] i , aequorin light signal decay time, and relaxation time in response to Iso stimulation (Fig. 5, C-F) . All parameters were not statistically different. 
Sln
Cre/ϩ mice were not susceptible to induction of AF by tachypacing. To evaluate electrical physiological properties, we induced AF and measured APD at 50%, 70%, and 90% repolarization in BCLs of 90, 120, and 150 ms, respectively (Fig. 6 ). There was no statistical difference between WT and Sln Cre/ϩ mice, although one of the Sln Cre/ϩ mice showed AF and two mice from each genotype showed repetitive atrial responses (Fig. 6C) .
Fibrosis was not prominent in Sln
Cre/ϩ atria under normal condition. The previous study (39) reported that increased interstitial fibrosis was higher in Sln-null mice compared with WT mice. Therefore, we evaluated the fibrosis level using picrosirius red staining and elastica van Gieson staining (Fig. 7) . We did not find any differences in positive areas stained with picrosirus red and elastica van Gieson in WT and Sln
Cre/ϩ atria. Sln Cre/ϩ mice showed a protective effect on fibrosis under chronic ␤-adrenergic stimulation. To investigate the effect on Sln heterozygous deletion under pathological conditions, we created the cardiac stress model with chronic ␤-adrenergic stimulation by Iso. After 2 wk of stimulation, the weight ratio of the tissues to body weight tended to increase in Iso-stimulated WT and Iso-stimulated Sln Cre/ϩ mice compared with saline-stimulated WT mice, although there was no statistical significance (Table 4 ). The echocardiography analysis showed that LVIDd and LVIDs were significantly increased in Iso-stimulated WT mice but not in Iso-stimulated Sln
Cre/ϩ mice (Table 5 ). Iso stimulation did not affect the level of Sln mRNA in either WT or Sln Cre/ϩ mice (saline-stimulated WT mice: 100 Ϯ 12.8%, Iso-stimulated WT mice: 87.5 Ϯ 12.1%, and Iso-stimulated Sln Cre/ϩ mice: 28.9 Ϯ 3.0%; Fig. 8 ). In addition, the level of procollagen type III mRNA was significantly increased in Iso-stimulated WT and Iso-stimulated Sln Cre/ϩ mice, whereas there was no significant difference in the level of other stress marker genes (Fig. 8) . Therefore, we measured fibrosis levels among saline-stimulated WT, Iso-stimulated WT, and Isostimulated Sln Cre/ϩ mice by picrosirius red and elastica van Gieson staining. Although fibrotic areas were significantly increased in both Iso-stimulated WT and Iso-stimulated Sln Cre/ϩ mice compared with saline-stimulated WT mice, the fibrosis level of Iso-stimulated Sln Cre/ϩ mice was significantly lower than that of Iso-stimulated WT mice (Fig. 9) .
DISCUSSION
SLN is specifically expressed in the atrium of the heart (21). Previous studies using SLN-null mice have demonstrated that contractility and Ca 2ϩ transients were significantly increased in SLN-deficient atria (3, 39) and that interstitial fibrosis was prominent in the atria of SLN KO mice (39) . Thus, SLN downregulation may enhance atrial contractile function and remodeling. However, previous studies have suggested that there is no significant phenotype in heterozygous SLN KO mice (3, 11, 26) , whereas limited data are available on the effect of the heterozygous SLN deletion. The present study demonstrated that SLN heterozygous deletion showed neither a molecular nor physiological cardiac phenotype at baseline. Values are expressed as means Ϯ SE; n ϭ 7 mice/group. There were no significant differences in any of the parameters.
There are several genes that show no phenotypic changes in response to heterozygous deletion through the mechanism of translation regulation (19, 29) . For example, mice with heterozygous deletion of the myosin light chain (MLC)2v gene showed normal cardiac function, whereas the homozygous MLC2v gene KO was embryonic lethal to mice because of cardiac failure (19) . The MLC2v protein expression level was not affected by heterozygous deletion, although its mRNA level in heterozygous KO mice was decreased to half the level of WT mice (19) . Alternatively, several actin isoforms were increased in ␣-actin-deficient mice to compensate for the lack of ␣-actin (16). In the Sln
Cre/ϩ heart, however, SLN protein Values are expressed as means Ϯ SE; n ϭ 7 mice/group. LVIDd and LVIDs in poststimulation isoproterenol-treated WT mice and HR in poststimulation isoproterenol-treated and Sln
Cre/ϩ mice were significantly increased compared with those in prestimulation isoproterenol-treated mice. In addition, HR in poststimulation isoproterenol-treated Sln Cre/ϩ mice was significantly higher than poststimulation saline-treated WT mice. *P Ͻ 0.05 and †P Ͻ 0.01 compared with prestimulation ‡P Ͻ 0.01 compared with saline-stimulated WT mice. Cre/ϩ mouse atria were significantly decreased similar to Sln Cre/ϩ mouse atria under normal condition. Expression levels of procollagen type III were significantly increased in both Iso-stimulated WT and Iso-stimulated Sln
Cre/ϩ atria. The expression level of GAPDH was used as an internal control. CTGF, connective tissue growth factor; LOX, lysyl oxidase. Values are expressed as means Ϯ SE; n ϭ 5-7. *P Ͻ 0.05 and ***P Ͻ 0.001 compared with saline-stimulated WT mice; † †P Ͻ 0.01 compared with WT mice. expression levels decreased to half those of WT mice and the level of PLN, the functional homolog of SLN, was not increased in Sln Cre/ϩ mouse atria. There were no significant functional changes in parameters throughout our experiments. Although it is not clear why the decrease in SLN protein levels in Sln
Cre/ϩ mouse atria did not induce any functional changes, it could be assumed that half the amount of SLN protein may be sufficient to maintain its function under normal cardiac conditions. In addition, the previous study (31) using both SLN and PLN double-KO mice showed a severe effect on atrial function and suggested that both SLN and PLN regulate SERCA activity in atria. Therefore, PLN in the atrium may have enough compensatory effect to maintain normal atrial function in Sln Cre/ϩ mouse atria, even though its protein level was not changed in the present study (Fig. 3) . This possibility has to be clarified in a future study to investigate the relationship between SERCA activity and the stoichiometric ratio of SERCA to Sln proteins.
We found no abnormalities in Sln Cre/ϩ mice atria under basal conditions. Next, we examined the effect of Sln heterozygous deletion under a cardiac stress condition by chronic Iso stimulation. Previous studies (5, 9, 15 ) have demonstrated that chronic Iso stimulation induces cardiac fibrosis, unchanged contractility, and significant increased HR. Although, in the present study, there was no significance among tissue-to-body weight ratios, consistent with previous studies, we found significant increased HR and fibrosis in Iso-stimulated WT mouse atria (Table 5 and Fig. 9 ). These data indicate that the chronic Iso-stimulated mouse in the present study is adequate as a cardiac stress model. Interestingly, two of seven mice in the Iso-stimulated WT group showed severe enlargement of LVIDd and LVIDs after chronic Iso stimulation (5.28 Ϯ 0.24 and 3.92 Ϯ 0.34, respectively, n ϭ 2), and HR in those two mice was decreased after chronic Iso stimulation rather than that before Iso infusion (before: 571 Ϯ 29 and after: 513 Ϯ 24, n ϭ 2). On the other hand, none of the seven mice in the Iso-stimulated Sln Cre/ϩ group showed severe enlargement of the LV and decreased HR after chronic Iso stimulation. We think that this is the reason why the statistical significances were observed in LV chamber size and HR between WT and Sln Cre/ϩ mice (Table 5) . Notably, fibrosis was less in Isostimulated Sln
Cre/ϩ mice than in Iso-stimulated WT mice (Fig.  9) . It should be noted that Xie et al. (39) demonstrated that fibrosis progressed more in atria of Sln KO mice than WT mice. At this moment, we cannot explain why the Sln heterozygous deletion prevented Iso-induced cardiac enlargement and Cre/ϩ atria with both stainings was significantly lower than WT atria (A and B). Values are expressed as means Ϯ SE; n ϭ 7. *P Ͻ 0.05, **P Ͻ 0.01, and ***P Ͻ 0.001 compared with saline-stimulated WT mice; † †P Ͻ 0.01 compared with WT mice. fibrosis, although Sln null deletion promoted atrial fibrosis at baseline. To investigate this discrepant effect, the further study is required using other stress models and/or by analyzing molecules involved in pathology.
Previous research has clarified that the atrium has distinct characteristics from the ventricle in terms of function and structure as well as gene expression and metabolic profile (4, 33, 36) . There are fewer studies on the atrium compared with those on the ventricle. One reason is that the strategy of the atrium-specific gene targeting has not been well developed. Therefore, we expected that the Sln Cre/ϩ mouse would be an effective tool to investigate the pathophysiology related to the atrium. Accordingly, Cre recombinase is specifically expressed in the atrium using Sln Cre/ϩ :R26R eYFP flox/ϩ mice at embryonic day 13.5 ( Fig. 1) . Several studies have already verified the usefulness of Sln Cre/ϩ mice to understand the mechanisms of heart development and cardiac function using deletion of the gene of interest from the atrium (11, 25, 26) .
In the present study, we showed the effects of SLN heterozygous deletion and the potentiality of Sln Cre/ϩ mice as atriumspecific gene-targeting mice. A previous study (6) has also reported using the Cre-loxP system with atrium-specific genetargeting mice. The Nppa-Cre transgenic mouse line was used to study atrial cardiomyocyte-specific Cre expression and to trace the atrial myocyte lineage (24) . However, the Nppa gene is a well-known biomarker of heart failure and is extensively induced into ventricular tissues under pathological conditions (8, 17) , which means that it is difficult to achieve an atriumspecific deletion of the gene of interest under pathological conditions such as cardiac hypertrophy and heart failure. SLN, however, is selectively expressed in the atrium from the early stage of heart development and throughout the entire lifespan (21, 25) . Several previous studies, including microarray analyses, have reported that SLN expression in the ventricle, in contrast to Nppa, is rarely induced under pathological conditions, whereas a reduction in SLN expression is often observed in the mouse atrium under stress conditions such as pressure overload, overexpression of the activated H-ras gene, and hyperthyroidism (9, 20 -22, 32, 34) . However, there are some exceptions. Pashmforoush et al. (27) and Spurney et al. (35) have reported that the SLN expression level was induced in the ventricle of ventricle-specific Nkx2.5 KO mice and dystrophindeficient mice. Moreover, it is very important and critical to know whether the Sln Cre/ϩ mouse exhibits abnormalities at an old age when these mice would be used for a long-term study of the atrium. Xie et al. (39) observed arrhythmia in SLN-null mice at an old age. Although we observed that both Sln Cre/ϩ and Sln
Cre/Cre mice were alive through the normal lifespan of ϳ2 yr, we did not examine arrhythmias in Sln Cre/ϩ mice at an old age. This should be addressed in our future study.
Taken together, we suggest that Sln Cre/ϩ mice have the advantage of generating atrium-specific gene-targeting mice and tracing atrial development compared with the Nppa-Cre transgenic line, even though we have to take care of some aspects such as the protective effect and aging in Sln Cre/ϩ mice. In conclusion, the present study revealed that the Sln Cre/ϩ mouse is not significantly different from the WT mouse in all aspects that were examined at the basal condition. Even though Sln
Cre/ϩ mice showed lower fibrosis compared with WT mice under cardiac stress by chronic Iso stimulation, we suggest that the Sln Cre/ϩ mouse can be reliably used to generate an atriumspecific conditional KO mouse.
